Child lung symptom clinic registry for Swiss families
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study collects information from children and teens (up to age 16) who are seen in a children’s lung clinic for breathing or respiratory problems in Switzerland. The goal is to better understand these conditions in everyday care, which may help improve future diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child is aged 0 to 16 years
- You live in Switzerland
- Your child has been seen at a children’s lung (pulmonary) clinic for breathing or respiratory problems
- A parent can sign the consent form, and if your child is over 14, the child can also sign
- Your child does NOT already have cystic fibrosis or primary ciliary dyskinesia
- Your child does NOT have certain serious health conditions (like severe heart disease, cancer, or major nerve/muscle disorders)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with wheezing (in younger kids) or doctor-diagnosed asthma (in older kids). It aims to better understand asthma and related breathing problems and how they develop over time.
This study looks at how the gut and lungs affect breathing problems in children. It compares samples from children with and without respiratory illnesses to understand why some children get sicker than others.
This study follows children and teens who are being checked for asthma for the first time. It aims to learn more about the early symptoms of asthma to improve diagnosis and treatment.
This study looks at young children (ages 1-5) who have had severe wheezing episodes that needed hospital care. It aims to find biomarkers (clues in the body) that could help predict which children might develop asthma later.
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
This study supports children ages 2–6 who have been diagnosed with preschool wheeze and need regular lung follow-up. It checks a “next step” approach for managing symptoms in children who already use inhaler medicine and have had recent wheezing episodes.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.